These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 19854299)

  • 1. Anti-angiogenic activity of triptolide in anaplastic thyroid carcinoma is mediated by targeting vascular endothelial and tumor cells.
    Zhu W; He S; Li Y; Qiu P; Shu M; Ou Y; Zhou Y; Leng T; Xie J; Zheng X; Xu D; Su X; Yan G
    Vascul Pharmacol; 2010; 52(1-2):46-54. PubMed ID: 19854299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A small-molecule triptolide suppresses angiogenesis and invasion of human anaplastic thyroid carcinoma cells via down-regulation of the nuclear factor-kappa B pathway.
    Zhu W; Ou Y; Li Y; Xiao R; Shu M; Zhou Y; Xie J; He S; Qiu P; Yan G
    Mol Pharmacol; 2009 Apr; 75(4):812-9. PubMed ID: 19158360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of triptolide on migration of vascular endothelial cells].
    Ding Y; Zhao QL; Li YG; Zhang J; Wang QL; Wang SR
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 May; 36(3):347-50. PubMed ID: 15931865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triptolide inhibits vascular endothelial growth factor expression and production in endothelial cells.
    Hu KB; Liu ZH; Guo XH; Liu D; Li LS
    Acta Pharmacol Sin; 2001 Jul; 22(7):651-6. PubMed ID: 11749832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of triptolide on anti-angiogenesis by reducing expression of urokinase plasminogen activator].
    Ding Y; Zhang J; Hou L; Zhang J; Wang Q; Wang S
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2005 Aug; 22(4):778-81. PubMed ID: 16156271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells.
    Jiang XH; Wong BC; Lin MC; Zhu GH; Kung HF; Jiang SH; Yang D; Lam SK
    Oncogene; 2001 Nov; 20(55):8009-18. PubMed ID: 11753684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triptolide inhibits tumor promoter-induced uPAR expression via blocking NF-kappaB signaling in human gastric AGS cells.
    Chang HJ; Kim MH; Baek MK; Park JS; Chung IJ; Shin BA; Ahn BW; Jung YD
    Anticancer Res; 2007; 27(5A):3411-7. PubMed ID: 17970088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effect of triptolide on lymph node metastasis in patients with non-Hodgkin lymphoma by regulating SDF-1/CXCR4 axis in vitro.
    Zhang C; Cui GH; Liu F; Wu QL; Chen Y
    Acta Pharmacol Sin; 2006 Nov; 27(11):1438-46. PubMed ID: 17049119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The homeobox gene Gax inhibits angiogenesis through inhibition of nuclear factor-kappaB-dependent endothelial cell gene expression.
    Patel S; Leal AD; Gorski DH
    Cancer Res; 2005 Feb; 65(4):1414-24. PubMed ID: 15735029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aplidin reduces growth of anaplastic thyroid cancer xenografts and the expression of several angiogenic genes.
    Straight AM; Oakley K; Moores R; Bauer AJ; Patel A; Tuttle RM; Jimeno J; Francis GL
    Cancer Chemother Pharmacol; 2006 Jan; 57(1):7-14. PubMed ID: 16001179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triptolide induces apoptosis in human anaplastic thyroid carcinoma cells by a p53-independent but NF-kappaB-related mechanism.
    Zhu W; Hu H; Qiu P; Yan G
    Oncol Rep; 2009 Dec; 22(6):1397-401. PubMed ID: 19885592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triptolide impairs dendritic cell migration by inhibiting CCR7 and COX-2 expression through PI3-K/Akt and NF-kappaB pathways.
    Liu Q; Chen T; Chen G; Shu X; Sun A; Ma P; Lu L; Cao X
    Mol Immunol; 2007 Apr; 44(10):2686-96. PubMed ID: 17223196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
    Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of triptolide on expression of urokinase-type plasminogen activators in vascular endothelial cells].
    Ding Y; Zhang J; Zhao QL; Hou LJ; Wang QL; Wang SR
    Ai Zheng; 2005 Jul; 24(7):801-5. PubMed ID: 16004804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxazosin inhibits human vascular endothelial cell adhesion, migration, and invasion.
    Keledjian K; Garrison JB; Kyprianou N
    J Cell Biochem; 2005 Feb; 94(2):374-88. PubMed ID: 15526277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
    Wood JM; Bold G; Buchdunger E; Cozens R; Ferrari S; Frei J; Hofmann F; Mestan J; Mett H; O'Reilly T; Persohn E; Rösel J; Schnell C; Stover D; Theuer A; Towbin H; Wenger F; Woods-Cook K; Menrad A; Siemeister G; Schirner M; Thierauch KH; Schneider MR; Drevs J; Martiny-Baron G; Totzke F
    Cancer Res; 2000 Apr; 60(8):2178-89. PubMed ID: 10786682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor alpha induces three-dimensional cytomorphologic differentiation of human anaplastic thyroid carcinoma cells through activation of nuclear factor kappaB.
    Wang CY; Zhong WB; Chang TC; Lai SM; Tsai YF
    Cancer; 2002 Nov; 95(9):1827-33. PubMed ID: 12404274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of tumor growth by targeting tumor endothelium using a soluble vascular endothelial growth factor receptor.
    Lin P; Sankar S; Shan S; Dewhirst MW; Polverini PJ; Quinn TQ; Peters KG
    Cell Growth Differ; 1998 Jan; 9(1):49-58. PubMed ID: 9438388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584.
    Qian DZ; Wang X; Kachhap SK; Kato Y; Wei Y; Zhang L; Atadja P; Pili R
    Cancer Res; 2004 Sep; 64(18):6626-34. PubMed ID: 15374977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triptolide suppresses interleukin-1beta-induced human beta-defensin-2 mRNA expression through inhibition of transcriptional activation of NF-kappaB in A549 cells.
    Jang BC; Lim KJ; Choi IH; Suh MH; Park JG; Mun KC; Bae JH; Shin DH; Suh SI
    Int J Mol Med; 2007 May; 19(5):757-63. PubMed ID: 17390080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.